Biocube Stock Performance
| BICB Stock | USD 0.0002 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and BioCube are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days BioCube has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental indicators, BioCube is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors. ...more
| Total Cashflows From Investing Activities | 210.00 |
BioCube |
BioCube Relative Risk vs. Return Landscape
If you would invest 0.02 in BioCube on October 11, 2024 and sell it today you would earn a total of 0.00 from holding BioCube or generate 0.0% return on investment over 90 days. BioCube is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than BioCube, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
BioCube Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioCube's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as BioCube, and traders can use it to determine the average amount a BioCube's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BICB |
Based on monthly moving average BioCube is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioCube by adding BioCube to a well-diversified portfolio.
BioCube Fundamentals Growth
BioCube Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of BioCube, and BioCube fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioCube Pink Sheet performance.
| Current Valuation | 3.84 M | |||
| Shares Outstanding | 44.84 M | |||
| Price To Earning | (0.65) X | |||
| Price To Sales | 0 X | |||
| EBITDA | 77.36 K | |||
| Cash And Equivalents | 39 | |||
| Total Debt | 1.03 M | |||
| Book Value Per Share | (0.04) X | |||
| Cash Flow From Operations | 210 | |||
| Earnings Per Share | (0.02) X | |||
| Total Asset | 100 K | |||
| Retained Earnings | (2.35 M) | |||
| Current Liabilities | 1.56 M | |||
About BioCube Performance
By analyzing BioCube's fundamental ratios, stakeholders can gain valuable insights into BioCube's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BioCube has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BioCube has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
BioCube, Inc., a development stage company, focuses on the development and marketing of lithium ion batteries in North America. The company was formerly known as Alliance Network Communications Holdings, Inc. and changed its name to BioCube, Inc. in December 2010. Biocube is traded on OTC Exchange in the United States.Things to note about BioCube performance evaluation
Checking the ongoing alerts about BioCube for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for BioCube help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BioCube generated a negative expected return over the last 90 days | |
| BioCube has some characteristics of a very speculative penny stock | |
| BioCube has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (534.8 K) with profit before overhead, payroll, taxes, and interest of 0. |
- Analyzing BioCube's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioCube's stock is overvalued or undervalued compared to its peers.
- Examining BioCube's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BioCube's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioCube's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BioCube's pink sheet. These opinions can provide insight into BioCube's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for BioCube Pink Sheet analysis
When running BioCube's price analysis, check to measure BioCube's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCube is operating at the current time. Most of BioCube's value examination focuses on studying past and present price action to predict the probability of BioCube's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCube's price. Additionally, you may evaluate how the addition of BioCube to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |